Drug Firms to Face Action for Violations in Pricing Norms

by Sam John Xavier on  May 19, 2017 at 12:46 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

200 pharma companies will be facing action, for launching new formulations or drugs without the approval of prices by The National Pharmaceutical Pricing Authority (NPPA).
Drug Firms to Face Action for Violations in Pricing Norms
Drug Firms to Face Action for Violations in Pricing Norms

"We have decided to take action against those (200) pharmaceutical companies which launched formulations or new drugs without even applying for our price approval as required under Para 15 (2) of the Drug Price Control Order (DPCO) 2013," said the watchdog in a statement here.

The companies have launched formulations by altering a schedule formation with dosage other than as specified in the DPCO, 2013 and combining with other non-schedule medicines.

Though the central government had issued the DPCO in 2013, the regulator found that the drug manufacturers have not complied with the provisions related to new drugs in the Essential Commodities Act, 1955.

The authority also directed the pharma industry association to obtain prior approval from it before launching any formulation that may be categorised as new drug.

The offending companies have to furnish production and sales details along with the corresponding MRP certified by a competent auditor for the formulations in the list along with the reasons for non-compliance of provisions related to new drugs.

As a state-run regulator, the NPPA controls the prices of pharmaceutical drugs across the country.

"With the number of cases being high (200), the Authority is not in a position to issue individual, 'show cause notice' due to manpower shortage," added the statement.



Source: IANS

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Nervous Tic Signature Drug Toxicity Drugs Banned in India 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...